BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Holistic medicine
,
Clofibrate
,
rs4950928
,
PBX1
,
Coagulation
,
Leukemia
,
Neuron
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
beta- 2- glycoprotein i
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Free Thiol β2-GPI (β-2-Glycoprotein-I) Provides a Link Between Inflammation and Oxidative Stress in …
The association of APOH and NCF1 polymorphisms on susceptibility to recurrent pregnancy loss in wome…
Genome-Wide Association Study Highlights APOH as a Novel Locus for Lipoprotein(a) Levels-Brief Repor…
Apolipoprotein H drives hepatitis B surface antigen retention and endoplasmic reticulum stress durin…
Correlation of Beta2-Glycoprotein I With Tumor Prognosis in Breast Cancer Patients.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Pharmacokinetic Study to Assess the Influence of P-glycoprotein Inhibition and Simultaneous CYP3A4…
PET Imaging of P-glycoprotein Function Using [11C]dLop
Biomarker for Mucolipidosis Disorder Type I, II, III, IV (BioML)
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
Phase I Study of Vaccination Schedule of Experimental HIV Vaccines
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ